
Bitnomial, the Chicago based cryptocurrency exchange, has launched the first Injective (INJ) futures contracts in the United States, regulated by the Commodity Futures Trading Commission.
Although access is currently limited to institutional clients, with retail traders expected to gain access in the future, the newly launched INJ futures contracts allow users to gain exposure to the Injective Protocol underlying INJ token without directly holding it.
The futures contracts settle in INJ with monthly expiries. This means that while the INJ futures contracts are tradable on the Bitnomial exchange, each contract has an expiry date. When this date is reached each month, the contract expires and settles.
The INJ futures contracts can also be margined in crypto or United States dollars, which means traders can choose to deposit either United States dollars or other supported cryptocurrencies as collateral when they open and maintain leveraged positions on the Bitnomial platform.
The launch of the Injective INJ futures contracts is one of several futures contract launches by Bitnomial this year, with the exchange having launched XRP futures contracts last month and Tezos and Aptos futures contracts earlier in the year.
The Injective protocol is a high performance layer 1 blockchain built for decentralized finance DeFi and other advanced financial applications. The Injective chain was built to support complex blockchain infrastructures such as decentralized exchanges DEXs, derivatives trading, perpetual futures, spot markets, prediction markets, lending, and real world assets RWAs.
Since its launch, several blockchain protocols have been built on the Injective chain, including Helix, a decentralized exchange, DojoSwap, an automated market maker, and Astroport.
In its latest acquisition move, Payward, the parent company of cryptocurrency exchange Kraken, has agreed to acquire Bitnomial for 550 million dollars in a deal expected to close before the end of the quarter.
Through this acquisition, Kraken aims to establish a fully vertically integrated United States crypto derivatives platform under full Commodity Futures Trading Commission regulation. The acquisition is intended to help Kraken accelerate the development of its derivatives business in the United States.
Bitnomial’s strong regulatory framework and compliance structure are among the factors influencing the deal. The company operates a Designated Contract Market, a Derivatives Clearing Organization, and a Futures Commission Merchant that supports its brokerage services.
Since Bitnomial already has these infrastructures in place, its acquisition is expected to be pivotal for Kraken in advancing its derivatives exchange objectives.